by North Woods | Jan 20, 2026 | Blog, Portfolio Spotlights
For millions of people living with glaucoma, treatment often begins with a familiar daily routine: prescription eye drops lined up on the bathroom counter, reminders taped to mirrors, and the quiet worry that missing a dose could allow the disease to progress. As...
by North Woods | Dec 15, 2025 | Blog, Portfolio Spotlights
For many families, the journey to an autism diagnosis begins with a quiet worry—a toddler who isn’t talking yet, a pediatrician who shares their concern, and then a waitlist that stretches six, twelve, sometimes even twenty-four months. In that time, the most powerful...
by North Woods | Dec 2, 2025 | Blog, Portfolio Spotlights
The untold story behind HistoSonics and the collisions that drive true medical breakthroughs By Dr. Joe Amaral, Chief Medical and Scientific Officer at Venture Investors Health Fund Innovation rarely happens in a straight line. It’s a story of collisions—between...
by North Woods | Sep 23, 2025 | Blog, Firm News
Photo: Rivermark team members (from left to right)—Tristen Moors, Vice President Clinical Operations; Jaime Walkowiak, Executive Vice President of Operations; Greg Borecki, Vice President Market Development; Adam Kadlec, President & CEO; Andy Doraiswamy, Board...
by North Woods | Sep 10, 2025 | Blog, Firm News
Madison, WI – September 10th 2025 – 9am CT – Venture Investors Health Fund (also known as “VI”) today announced the successful close of its seventh fund, raising $80 million to drive breakthrough healthcare innovations that aim to fundamentally...
